Woodland Translational Research-Canada to Present In Vivo Capabilities at Symposium

LAVAL, Quebec - June 22, 2016 - PRLog -- Woodland Translational Research-Canada announced today that its President Dr. Michael Briggs, is a featured speaker at the Discovery to Development VII Symposium:  Screening & Testing in the Current Era.  The symposium is held at CNBE-INRS and co-hosted by CiTox Labs.  Dr. Briggs will present on the topic of Translational NASH Modeling in Mice-Steatosis, Inflammation, Fibrosis and Liver Cancer, and announce the availability of these models in Canada.

About Woodland Translational Research-Canada

Woodland is an in vivo CRO supplying mouse models of oncology and metabolic diseases, and also mouse-based pharmacokinetics for preclinical development.  Woodland specializes in liver diseases and maintains labs in Massachusetts, as "Woodland Biosciences" and Quebec as "Woodland Translational Research-Canada."  Woodland is a founding member of the Northeast Preclinical Network, along with CNBE-INRS which offers integrated services supplied by individual specialist members.  Please visit the main Woodland Biosciences website: http://www.woodlandbiosciences.com/   Please review the agenda of the symposium at this link. (http://us8.campaign-archive2.com/?u=030248528531c08bbad59...)